At a glance
ClinicalIndex Comparison RecordN/ACompleted· 36 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Screening Protocol for a Dose Finding Human Experimental Infection Study in Healthy Subjects Using a GMP-produced SARS-COV-2 Wild Type Strain
In Brief
An observational study for Covid19. Completed, enrolled 36 participants across 1 site.
Detailed Summary
The aim of this screening protocol is to assess volunteers for their potential eligibility to participate in a dose finding human experimental infection study in healthy subjects using a GMP-produced SARS-CoV-2 wild type strain
Study Details
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartDec 2020
First PostedFeb 2021
Primary CompletionJun 2021
Study CompletionJul 2021
TodayJul 2026
First PostedFeb 5, 2021
Enrollment StartDec 15, 2020
Primary CompletionJun 23, 2021
Study CompletionJul 9, 2021
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 5.4 years ago